Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 9/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | CCR1 | P32246 | 1/20 | 0.40 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
| ▸ | CCR8 | P51685 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | ABAT | P80404 | 1/20 | 0.40 |
| ▸ | RRM2 | P31350 | 1/20 | 0.40 |
| ▸ | LOX | P28300 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25162016 | 0.86 | ADRB2 (0.41) | LOXL2HRH3ADRB2ABATRRM2 | |
| SCHEMBL31120747 | 0.85 | KDM4E (0.54) | LOXL2ADRB2CCR1CCR5CCR8 | |
| SCHEMBL12486607 | 0.85 | KDM4E (0.54) | LOXL2ADRB2CCR1CCR5CCR8 | |
| SCHEMBL1720975 | 0.83 | CYP11B1 (0.59) | LOXL2CYP2A6CYP11B1CYP11B2TAAR1 | |
| SCHEMBL30083539 | 0.83 | CYP11B1 (0.59) | LOXL2CYP2A6CYP11B1CYP11B2TAAR1 | |
| SCHEMBL14355099 | 0.81 | CYP11B1 (0.57) | LOXL2ADRB2CYP2A6CYP11B1CYP11B2 | |
| Hydrochloric Acid SCHEMBL5010818 | 0.81 | CYP11B1 (0.57) | LOXL2CYP11B1CYP11B2TAAR1 | |
| SCHEMBL28956571 | 0.80 | AOC3 (0.39) | LOXL2CCR1CCR5CCR8HDAC6 | |
| Hydrochloric Acid SCHEMBL31716140 | 0.80 | CYP11B1 (0.54) | LOXL2HRH3ADRB2CYP11B1CYP11B2 | |
| SCHEMBL6673316 | 0.80 | AURKA (0.54) | HRH3CCR1CCR5CCR8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8951400-B2 | Chemistry used in biosensors | OHMX CORPORATION (US) | 2015-02-10 | — | — | US | disclosed |
| WO-2012012537-A1 | NOVEL CHEMISTRY USED IN BIOSENSORS | OHMX CORPORATION (US) | 2012-01-26 | — | — | WO | disclosed |
| US-20120012472-A1 | NOVEL CHEMISTRY USED IN BIOSENSORS | OHMX CORPORATION (US) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120012472-A1 | NOVEL CHEMISTRY USED IN BIOSENSORS | SSBP1, OSGEP, OCIAD2 | LOXL2 2384/4885HRH3 4746/4885ADRB2 4452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.